[Results of coronary artery bypass grafting in patients of different age groups]

R S Tarasov1, A N Kazantsev2, K K Glebov1

  • 1Scientific Research Institute for Complex Problems of Cardiovascular Diseases, Kemerovo, Russia.

Insights

Coronary artery bypass grafting outcomes vary by age, with older patients (over 75) experiencing more bleeding complications. Personalized treatment strategies are crucial for optimal results in myocardial revascularization.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Geriatric Medicine

Background:

  • Myocardial revascularization addresses ischemic heart disease using various invasive methods.
  • Patient age is a significant factor influencing treatment strategies and outcomes.

Purpose of the Study:

  • To investigate the outcomes of coronary artery bypass grafting (CABG) across different age groups.
  • To identify age-related differences in complication rates following CABG.

Main Methods:

  • A cohort of 905 patients undergoing CABG was stratified into four age groups: young, middle, old, and senile.
  • Follow-up endpoints included myocardial infarction, stroke, death, and hemorrhagic complications.

Main Results:

  • No significant differences in overall postoperative complication rates were observed between age groups.
  • Patients over 75 years old showed a higher incidence of mediastinal revision due to hemorrhage.

Conclusions:

  • Age groups undergoing CABG exhibit significant heterogeneity in clinical and intraoperative characteristics.
  • Increased hemorrhagic complications in older patients may stem from aggressive anticoagulation/antiplatelet therapy, often due to atrial fibrillation.
  • An individualized approach to revascularization strategy is paramount for optimizing outcomes in coronary surgery.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
922
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
391
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
192
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
223
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
246
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
345